<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Spinal cord infarction: Treatment and prognosis</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Spinal cord infarction: Treatment and prognosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Spinal cord infarction: Treatment and prognosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael T Mullen, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael L McGarvey, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott E Kasner, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alejandro A Rabinstein, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Richard P Goddeau, Jr, DO, FAHA</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Spinal cord infarction is a rare but often devastating vascular disorder caused by one of several etiologies. Patients typically present with acute paraparesis or quadriparesis, depending on the level of the spinal cord involved. The severity can vary, and while many patients make some functional recovery, permanent and disabling neurologic deficits remain in many. Specific treatment options are limited.</p><p>This topic will review the acute treatment and prognosis of spinal cord infarction. The etiologies, clinical features, diagnosis, and chronic complications of spinal cord infarction are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1125.html" rel="external">"Spinal cord infarction: Epidemiology and etiologies"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1117.html" rel="external">"Spinal cord infarction: Clinical presentation and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease"</a>.)</p><p></p><p>The management of acute traumatic spinal cord injury is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/4819.html" rel="external">"Acute traumatic spinal cord injury"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">TREATMENT</span></p><p class="headingAnchor" id="H578184923"><span class="h2">Acute management</span><span class="headingEndMark"> — </span>The management of patients with acute spinal cord infarction begins with identifying or excluding high-risk causes such as aortic dissection that require specific treatment to prevent further morbidity. Overall treatment of spinal cord ischemia is directed toward minimizing or reversing neurologic dysfunction and is guided by principles of cerebral infarction and traumatic spinal cord injury. This generally involves optimizing spinal cord perfusion and initiating cause-specific secondary preventive therapies. However, evidence of efficacy for these treatment options used for spinal cord infarction is limited.</p><p class="headingAnchor" id="H2096056609"><span class="h3">Identify high-risk underlying causes that require urgent treatment</span><span class="headingEndMark"> — </span>The etiology of spinal cord infarction may be apparent in some cases, such as when symptoms occur in the setting of aortic or spinal surgery or during severe systemic hypoperfusion (eg, cardiac arrest). In other cases, the etiology of spinal cord infarction may be uncertain despite initial clinical examination and diagnostic spinal imaging. For patients with an uncertain cause of spinal cord infarction, further diagnostic testing is warranted to identify underlying causes.</p><p>Patients with clinical features of or risk factors for high-risk underlying causes of spinal cord infarction require urgent evaluation to guide specific acute treatment and reduce the immediate risk of further morbidity. As examples, this includes patients with spinal cord infarction and additional clinical features or risk factors suggestive of:</p><p class="bulletIndent1"><span class="glyph">●</span>Aortic dissection, aneurysm, or thrombosis (eg, hemodynamic instability, severe chest/back pain, reduced/asymmetric peripheral pulses)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vertebral artery dissection (eg, rostral spinal cord infarction, associated brainstem symptoms)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Infective endocarditis (eg, fever, new heart murmur)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bacterial meningitis (eg, fever, meningismus)</p><p></p><p>Etiologic testing to identify the underlying cause of spinal cord infarction is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1117.html" rel="external">"Spinal cord infarction: Clinical presentation and diagnosis", section on 'Testing for underlying cause'</a>.)</p><p class="headingAnchor" id="H1608381582"><span class="h3">Addressing spinal cord hypoperfusion</span><span class="headingEndMark"> — </span>Spinal cord infarction may be caused by systemic hypotension or other conditions that cause hypoperfusion of the spinal cord, such as aortic surgery. Strategies to improve inadequate spinal cord perfusion may halt or reverse progression of neurologic symptoms due to acute spinal cord infarction in some patients. Treatment options vary by individual clinical circumstances and available resources. These include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Correct systemic hypotension</strong> – Correction of hypotension, if present, is typically the first step to improve neurologic deficits due to presumed spinal cord hypoperfusion. This may involve administration of intravenous fluids and/or treatment of specific conditions such as heart failure or anemia.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Trial of blood pressure augmentation with vasopressors</strong> – We attempt a trial of blood pressure augmentation for patients with possible reversible spinal hypoperfusion, such as patients who present acutely (eg, &lt;24 hours), patients with systemic hypotension unresponsive to fluid resuscitation, and those whose symptoms fluctuate with blood pressure changes or improve with recumbent/Trendelenburg positioning. Reversal of neurologic deficits has been reported with blood pressure augmentation in some cases of acute spinal cord infarction due to aortic surgery [<a href="#rid1">1,2</a>] and other cases when symptoms fluctuated with blood pressure changes [<a href="#rid3">3</a>].</p><p></p><p class="bulletIndent1">The specific blood pressure goal is uncertain. Some experts use a trial of increasing mean arterial perfusion (MAP) to 70 to 85 mmHg or a target MAP of 10 to 20 mmHg above baseline while monitoring for neurologic improvement [<a href="#rid4">4</a>]. An alternative approach for patients with a lumbar drain is to titrate MAP to achieve a spinal perfusion pressure &gt;60 mmHg [<a href="#rid5">5</a>]. Treatment is typically weaned after 24 to 48 hours as tolerated or if contraindications develop. Prerequisites of these treatments include excluding aortic dissection and hemorrhagic causes of symptoms which may worsen with blood pressure augmentation.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Placement of lumbar drain with goal intracranial pressure</strong> – The placement of a lumbar drain may improve spinal cord perfusion by reducing intracranial and intraspinal pressure. A lumbar drain is typically used prophylactically to prevent spinal cord infarction from aortic surgery [<a href="#rid6">6</a>]. It may be also be attempted for other patients who present acutely (eg, &lt;24 hours) with nonoperative causes of spinal cord infarction, although efficacy data of lumbar drainage in this setting are unavailable. (See <a class="local">'Following aortic surgery or endovascular repair'</a> below.)</p><p></p><p class="bulletIndent1">The optimal intracranial pressure target to treat spinal cord ischemia for patients with a lumbar drain is uncertain. We suggest draining cerebrospinal fluid either to a target pressure of 10 to 15 mmHg or at a rate of 10 to 20 mL each hour [<a href="#rid7">7</a>]. We monitor clinically for 24 to 48 hours to assess for improvement of neurologic symptoms then wean step-wise while monitoring for neurologic stability. Lumbar drains are associated with a risk of spinal epidural bleeding or abscess and intracranial hypotension syndrome [<a href="#rid6">6,8,9</a>] and should be used by experienced clinicians in centers experienced with this technique, such as a neurocritical care unit.</p><p></p><p class="headingAnchor" id="H3193863561"><span class="h3">Therapies of uncertain or limited benefit</span></p><p class="headingAnchor" id="H1384053484"><span class="h4">Thrombolytic treatment</span><span class="headingEndMark"> — </span>Thrombolytic therapy for spinal cord ischemia remains investigational. Protocols for spinal cord infarcts typically follow dosing and inclusion/exclusion criteria used for ischemic cerebral infarction. However, the efficacy and safety of this treatment for spinal cord infarction is uncertain. Thrombolytic therapy has been utilized for spinal cord infarction with apparent success in only a few published case reports [<a href="#rid10">10-13</a>]. (See  <a class="medical medical_review" href="/z/d/html/16134.html" rel="external">"Intravenous thrombolytic therapy for acute ischemic stroke: Therapeutic use"</a>.)</p><p>A significant barrier to thrombolytic treatment in this situation is the initial diagnostic uncertainty that can delay diagnosis beyond the acute thrombolytic treatment window; this includes the need to exclude aortic dissection and spinal vascular malformations, which are contraindications to thrombolytic therapy.</p><p class="headingAnchor" id="H150640574"><span class="h4">Glucocorticoids</span><span class="headingEndMark"> — </span>For most patients with spinal cord infarction, we <strong>avoid</strong> glucocorticoids. Glucocorticoids are not recommended in acute ischemic stroke of the brain, and their benefit in ischemic injury to the spinal cord is unproven [<a href="#rid14">14,15</a>]. In addition, glucocorticoids may worsen neurologic deficits in patients with initially suspected spinal cord infarction who are subsequently found to have myelopathy from a spinal arteriovenous fistula [<a href="#rid16">16</a>].</p><p>Glucocorticoids may be administered to select patients with spinal cord infarction determined to be due to an inflammatory condition such as vasculitis. In addition, it may be reasonable to use glucocorticoids to treat progressive myelopathic symptoms when transverse myelitis is suspected but discriminating between ischemic and demyelinating causes is difficult or delayed. The use of glucocorticoids for these conditions is discussed in detail separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/8224.html" rel="external">"Overview of the management of vasculitis in adults", section on 'Approach to treatment'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/142457.html" rel="external">"Transverse myelitis: Treatment and prognosis"</a>.)</p><p></p><p class="headingAnchor" id="H3746429620"><span class="h3">Treatment for specific underlying causes</span><span class="headingEndMark"> — </span>Diagnostic evaluation of spinal cord infarction includes assessment of underlying causes. While the etiology of a spinal cord infarct may not be immediately apparent in some cases, clinical circumstances and initial diagnostic testing may identify the cause in other cases (eg, aortic dissection, systemic hypoperfusion, vascular malformation, vertebral artery dissection). Treatment of underlying etiologies may help to hasten recovery, prevent further neurologic deterioration, and reduce the risk of other cause-specific complications. (See  <a class="medical medical_review" href="/z/d/html/1125.html" rel="external">"Spinal cord infarction: Epidemiology and etiologies", section on 'Etiologies'</a>.)</p><p class="headingAnchor" id="H3710982076"><span class="h4">Aortic dissection and other acute aortic conditions</span><span class="headingEndMark"> — </span>Patients with spinal cord infarction due to hypoperfusion from aortic dissection, aneurysm, or thrombosis may require urgent evaluation and treatment of the aortic condition. Acute treatment of these conditions may take priority over treatment of spinal cord infarction to reduce the risk of mortality or progressive morbidity. This includes patients with hemodynamic instability and those with high-risk findings on diagnostic testing. The management of these acute aortic conditions is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes", section on 'Management'</a>.)</p><p class="headingAnchor" id="H1375818259"><span class="h5">Following aortic surgery or endovascular repair</span><span class="headingEndMark"> — </span>A specific protocol has been developed that appears to be effective in reversing or limiting the neurologic deficits from spinal cord ischemia after aortic surgery and thoracic endovascular aortic repair (TEVAR) [<a href="#rid7">7,17-19</a>]. This employs a combination of blood pressure support and reduction of spinal cord canal pressure with lumbar drains  (<a class="graphic graphic_algorithm graphicRef51097" href="/z/d/graphic/51097.html" rel="external">algorithm 1</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>MAP is increased in increments of 10 mmHg every five minutes (with volume and vasopressor agents) until symptoms resolve, bleeding complications ensue, or additional blood pressure augmentation would cause an unacceptably high risk of bleeding at the surgical bed.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If a lumbar drain is in place, it should be opened and set to drain at 8 to 12 mmHg. If not in place, a lumbar drain should be placed if there is no response to blood pressure augmentation within 10 to 20 minutes.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>If there is no response to treatment, spinal imaging is performed to exclude epidural hematoma. Magnetic resonance imaging (MRI) is preferred, but in cases where MRI is contraindicated or the patient is not stable enough to undergo MRI, computed tomography (CT) is performed as an alternative study.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vasopressors are slowly weaned over the ensuing 24 to 48 hours with close monitoring of neurologic function. After vasopressor support is weaned, the lumbar drain should be capped then removed 24 hours later if neurologic function remains stable.</p><p></p><p>While this protocol has not been evaluated in a controlled study, the temporal association of the intervention with the observation of improvement in some cases provides evidence of its efficacy. Nonetheless, the number of patients in whom this treatment has been reported is small [<a href="#rid20">20</a>].</p><p>The use of this treatment protocol in spinal cord infarction due to other causes has not been studied. While these interventions could be considered, the benefit is questionable, particularly given the usually long delay from onset of symptoms to initiation of therapy in these settings.</p><p class="headingAnchor" id="H1770590199"><span class="h5">Thrombotic complication of venoarterial extracorporeal membrane oxygenation</span><span class="headingEndMark"> — </span>Spinal cord infarction may occur as a complication of peripheral venoarterial extracorporeal membrane oxygenation (V-A ECMO).</p><p>Management of these critically ill patients can be challenging due to ongoing need for V-A ECMO and anticoagulation and because required monitoring and treatment regimens can limit access to spinal cord imaging. Intensity of anticoagulation is typically increased in patients with aortic thrombosis, if possible. (See  <a class="medical medical_review" href="/z/d/html/134279.html" rel="external">"Extracorporeal life support in adults: Management of venoarterial extracorporeal membrane oxygenation (V-A ECMO)", section on 'Cardiac or aortic thrombosis'</a>.)</p><p>Other measures for patients with spinal cord infarction in the setting of V-A ECMO may include a trial of blood pressure augmentation and/or placement of a lumbar drain to reduce intraspinal pressure, if possible. However, use of lumbar drains is often limited by ongoing anticoagulation and severity of illness. If possible, removal of the V-A ECMO device or modification of cannula sites can be considered.</p><p class="headingAnchor" id="H194115841"><span class="h4">Spinal vascular malformation</span><span class="headingEndMark"> — </span>Spinal vascular malformations may be identified by spinal MRI or spinal angiography. Repair of the malformation may prevent further neurologic decline and, in some instances, lead to improved neurologic function [<a href="#rid21">21,22</a>]. (See  <a class="medical medical_review" href="/z/d/html/5093.html" rel="external">"Disorders affecting the spinal cord", section on 'Vascular malformations'</a>.)</p><p class="headingAnchor" id="H2593655697"><span class="h4">Vertebral artery dissection</span><span class="headingEndMark"> — </span>Patients with cervical spinal cord infarction due to vertebral artery dissection are managed in the same manner as patients with cerebral infarction from dissection. Treatment consists of reperfusion therapy for eligible patients, antithrombotic therapy, blood pressure management, and control of metabolic derangements. The management of patients with vertebral artery dissection is discussed in greater detail separately. (See  <a class="medical medical_review" href="/z/d/html/16649.html" rel="external">"Cerebral and cervical artery dissection: Treatment and prognosis"</a>.)</p><p class="headingAnchor" id="H2338877997"><span class="h4">Cryptogenic</span><span class="headingEndMark"> — </span>The underlying cause of spinal cord infarction may remain uncertain even after a thorough diagnostic evaluation (see  <a class="medical medical_review" href="/z/d/html/1117.html" rel="external">"Spinal cord infarction: Clinical presentation and diagnosis", section on 'Testing for underlying cause'</a>). For patients with a cryptogenic spinal cord infarction, we typically start antithrombotic therapy with <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> at 81 mg daily.</p><p>We also use high-dose statins (hydroxymethylglutaryl CoA reductase inhibitors) when atherosclerotic risk factors are present and treat for other cerebrovascular risk factors such as hypertension and diabetes mellitus, similar to patients with ischemic cerebral stroke. (See  <a class="medical medical_review" href="/z/d/html/1119.html" rel="external">"Overview of secondary prevention for specific causes of ischemic stroke and transient ischemic attack"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Prevention and management of complications</span><span class="headingEndMark"> — </span>Patients with spinal cord infarction are at risk for systemic as well as neurologic complications, typically in the first days and weeks after symptom onset. Some of these can exacerbate the neurologic injury and may be life-threatening. Early intervention can avoid and ameliorate the risk of complication-related morbidity and mortality.</p><p class="headingAnchor" id="H3849419966"><span class="h3">General measures</span><span class="headingEndMark"> — </span>Patients with moderate to severe acute deficits resulting from a high thoracic or cervical cord infarct should be admitted to an intensive care unit with close monitoring of vital signs and neurologic status. Spinal cord infarction involving these rostral levels is associated with an elevate risk of hemodynamic instability, respiratory failure, and other cardiorespiratory complications.</p><p class="headingAnchor" id="H4"><span class="h3">Cardiovascular complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hemodynamic instability and neurogenic shock</strong> – Hypo- and hypertension may accompany neurologic symptoms in cervical and rostral thoracic infarcts. Blood pressure abnormalities may also lead to myocardial infarction or impairment of kidney function and may also worsen neurologic symptoms.</p><p></p><p class="bulletIndent1">Neurogenic shock refers to hypotension, usually with bradycardia, attributed to interruption of autonomic pathways in the spinal cord causing decreased vascular resistance. Patients with spinal cord infarction may also have hemodynamic instability related to the underlying etiology.</p><p></p><p class="bulletIndent1">An adequate blood pressure is believed to be critical in maintaining adequate perfusion to the ischemic, but not yet infarcted, spinal cord. Close monitoring with symptomatic treatment is warranted to minimize these effects. (See  <a class="medical medical_review" href="/z/d/html/4819.html" rel="external">"Acute traumatic spinal cord injury"</a>.)</p><p></p><p class="bulletIndent1">Bradycardia can occur in severe, high cervical (C1 through C5) lesions and may require external cardiac pacing or administration of <a class="drug drug_general" data-topicid="8983" href="/z/d/drug information/8983.html" rel="external">atropine</a>.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Autonomic dysreflexia</strong> – Autonomic dysreflexia, a phenomenon characterized by episodic paroxysmal hypertension with headache, bradycardia, flushing, and sweating, is most often described after a traumatic spinal cord injury, but may also occur in the subacute or chronic phases after a spinal cord infarction involving the cervical or upper thoracic cord.</p><p></p><p class="bulletIndent1">Management strategies to reduce frequency and severity of episodes include careful monitoring and optimization of blood pressure, treating pain and avoiding other triggers (eg, bladder distention), and the use of agents such as <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">nifedipine</a> to prevent attacks. (See  <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease", section on 'Autonomic dysreflexia'</a>.)</p><p></p><p class="headingAnchor" id="H5"><span class="h3">Pulmonary complications</span><span class="headingEndMark"> — </span>Several pulmonary complications may accompany spinal cord infarction, especially with cervical lesions and high thoracic lesions. Weakness of the diaphragm and chest wall muscles leads to impaired clearance of secretions, ineffective cough, atelectasis, and hypoventilation. (See  <a class="medical medical_review" href="/z/d/html/5119.html" rel="external">"Respiratory physiologic changes following spinal cord injury"</a>.)</p><p>Pulmonary complications include:</p><p class="bulletIndent1"><span class="glyph">●</span>Acute respiratory failure</p><p class="bulletIndent1"><span class="glyph">●</span>Pneumonia</p><p class="bulletIndent1"><span class="glyph">●</span>Pulmonary edema</p><p></p><p>Chest physical therapy should be started for patients with ineffective cough or impaired clearance of secretions to prevent atelectasis and pneumonia. Sputum Gram stain and culture are warranted for patients with pneumonia to help guide antibiotic therapy. These issues are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/5120.html" rel="external">"Respiratory complications in the adult patient with chronic spinal cord injury", section on 'Pulmonary infection'</a>.)</p><p>Patients with spinal cord infarction should be monitored for respiratory insufficiency. Signs of impending respiratory failure include increased respiratory rate, declining forced vital capacity, rising partial pressure of carbon dioxide (pCO<sub>2</sub>), or falling partial pressure of oxygen (pO<sub>2</sub>) and may indicate a need for intubation and ventilation with positive pressure support. Patients with respiratory failure who require intubation may need respiratory muscle training to wean from ventilatory support, and some may require long-term assisted ventilation. (See  <a class="medical medical_review" href="/z/d/html/5120.html" rel="external">"Respiratory complications in the adult patient with chronic spinal cord injury", section on 'Respiratory insufficiency'</a>.)</p><p class="headingAnchor" id="H6"><span class="h3">Venous thromboembolism and pulmonary embolism</span><span class="headingEndMark"> — </span>All patients with immobility due to acute spinal cord infarction should receive prophylaxis for deep venous thrombosis. We consider patients with acute spinal cord infarction to have a similar risk to those with acute spinal cord traumatic injury and treat accordingly. Specific recommendations are provided separately. (See  <a class="medical medical_review" href="/z/d/html/5120.html" rel="external">"Respiratory complications in the adult patient with chronic spinal cord injury", section on 'Prophylaxis'</a>.)</p><p class="headingAnchor" id="H168771258"><span class="h3">Other medical complications</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pressure sores</strong> – Pressure sores are most common on the buttocks and heels and can develop quickly in immobilized patients. Such patients should be turned side to side (log-rolled) every two to three hours to avoid pressure sores. Special mattresses can also be used to ameliorate this complication. (See  <a class="medical medical_review" href="/z/d/html/2885.html" rel="external">"Prevention of pressure-induced skin and soft tissue injury", section on 'Support surfaces'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urinary catheterization</strong> – Patients with moderate to severe deficits including bladder dysfunction initially require an indwelling urinary catheter to avoid bladder distension. Three or four days after injury, intermittent catheterization should be substituted, as this reduces the incidence of bladder infections. (See  <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease", section on 'Bladder dysfunction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastrointestinal stress ulceration</strong> – Patients with spinal cord infarction, particularly those that affect the cervical cord, are at high risk for stress ulceration and should receive prophylaxis with proton pump inhibitors. (See  <a class="medical medical_review" href="/z/d/html/1611.html" rel="external">"Stress ulcers in the intensive care unit: Diagnosis, management, and prevention"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temperature control</strong> – Patients with a cervical spinal cord injury may lack vasomotor control and be unable to sweat below the lesion. Their temperature may vary with the environment and need to be maintained.</p><p></p><p class="headingAnchor" id="H11"><span class="h3">Functional recovery</span><span class="headingEndMark"> — </span>Physical and occupational therapy should be started as soon as possible. Patients with neurologic dysfunction due to spinal cord infarction should be screened for depression, and counseling should be included as part of comprehensive rehabilitation, as indicated.</p><p class="headingAnchor" id="H13"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>Functional outcome after spinal cord infarct varies according to the spinal level and severity of initial neurologic deficits. Many patients improve with rehabilitation and time, but most have some persistent dysfunction. Case series and cohort studies have attempted to define the range of outcomes following spinal cord infarction.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Case fatality</strong> – The case fatality rate varies depending on the case mix included in the series but is often reported between 10 and 23 percent [<a href="#rid20">20,23-26</a>]. Patients presenting in the setting of cardiac arrest and acute aortic rupture or dissection and those with high cervical lesions are at greatest risk of death. Patients with spinal cord infarction have a higher mortality rate after hospital discharge, in part related to the high prevalence of underlying vascular risk factors [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Functional outcomes</strong> – Among survivors, most make some improvement in functional deficits. Independent gait is achieved by 11 to 46 percent, while 20 to 62 percent remain nonambulatory [<a href="#rid20">20,23-25,28-32</a>]. Outcomes may be better among patients with spontaneous compared with periprocedural spinal cord infarcts [<a href="#rid32">32</a>]. One case series with prolonged follow-up noted that gradual improvement occurred in many patients at long-term follow-up (mean three years) after hospital discharge [<a href="#rid26">26</a>].</p><p></p><p class="bulletIndent1">Poor prognostic factors for recovery include severe impairment at presentation, female sex, advanced age, and lack of improvement in the first 24 hours [<a href="#rid23">23,25,26,28-30,33,34</a>].</p><p></p><p class="bulletIndent1">Patients with residual deficits after spinal cord infarction must often contend with a variety of other complications including bladder, bowel, and sexual dysfunction, spasticity, and chronic pain. These conditions are discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/4839.html" rel="external">"Chronic complications of spinal cord injury and disease"</a>.)</p><p></p><p class="headingAnchor" id="H1169370620"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/105370.html" rel="external">"Society guideline links: Stroke in adults"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Acute treatment</strong> – The acute treatment of spinal cord infarction begins with identifying or excluding high-risk causes such as aortic dissection that require specific treatment to prevent further morbidity. Specific treatment of spinal cord infarction is directed toward minimizing or reversing neurologic dysfunction. Treatment generally involves optimizing spinal cord perfusion and initiating cause-specific secondary preventive therapies. (See <a class="local">'Acute management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluate for high-risk causes</strong> – Patients with clinical features or risk factors for high-risk causes require urgent evaluation to guide specific acute treatment and reduce immediate risk of further morbidity. This includes patients with spinal cord infarction and additional clinical features or risk factors suggestive of (see <a class="local">'Identify high-risk underlying causes that require urgent treatment'</a> above):</p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Aortic dissection</p><p class="bulletIndent3"><span class="glyph">-</span>Vertebral artery dissection</p><p class="bulletIndent3"><span class="glyph">-</span>Infective endocarditis</p><p class="bulletIndent3"><span class="glyph">-</span>Bacterial meningitis</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Strategies to optimize spinal cord perfusion</strong> – Strategies to improve inadequate spinal cord perfusion may halt or reverse progression of neurologic symptoms due to acute spinal cord infarction in some patients. Treatment options vary by individual clinical circumstances and available resources and include treating systemic hypotension, augmenting blood pressure with vasopressors, and/or using a lumbar drain to reduce intraspinal pressure and improve spinal perfusion. (See <a class="local">'Addressing spinal cord hypoperfusion'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Treat underlying causes</strong> – Underlying etiologies should be identified and treated to help hasten recovery, prevent further deterioration, and reduce the risk of other cause-specific complications. (See <a class="local">'Treatment for specific underlying causes'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management of complications</strong> – Patients with spinal cord infarction are at risk for systemic as well as neurologic complications, typically in the first days and weeks after symptom onset. Early intervention can avoid and ameliorate the risk of complication-related morbidity and mortality. (See <a class="local">'Prevention and management of complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Triage</strong> – Patients with moderate to severe deficits resulting from a high thoracic or cervical cord infarct should be admitted to an intensive care unit with close monitoring of vital signs and neurologic status. (See <a class="local">'General measures'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Hemodynamic instability</strong> – Hemodynamic monitoring with symptomatic treatment of abnormal blood pressure and/or heart rate is warranted. Management strategies to reduce frequency and severity of autonomic instability include careful monitoring and optimization of blood pressure, treating pain and avoiding other triggers (eg, bladder distention), and the use of agents such as <a class="drug drug_general" data-topicid="9700" href="/z/d/drug information/9700.html" rel="external">nifedipine</a> to prevent attacks. (See <a class="local">'Cardiovascular complications'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Respiratory insufficiency and infection</strong> – Chest physical therapy should be started for patients with ineffective cough or impaired clearance of secretions to prevent atelectasis and pneumonia. Patients with signs of impending respiratory failure may need intubation and ventilation with positive pressure support, including those with increased respiratory rate, declining forced vital capacity, rising partial pressure of carbon dioxide (pCO<sub>2</sub>), or falling partial pressure of oxygen (pO<sub>2</sub>) levels. (See <a class="local">'Pulmonary complications'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Deep venous thrombosis</strong> – All patients with immobility due to acute spinal cord infarction should receive prophylaxis for deep venous thrombosis. (See <a class="local">'Venous thromboembolism and pulmonary embolism'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Other complications</strong> – Patients with spinal cord infarction should also be assessed for other medical complications common in hospitalized or immobilized patients such as pressure sores, urinary dysfunction, gastrointestinal stress ulcers, and temperature dysregulation. (See <a class="local">'Other medical complications'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Prognosis</strong> – Functional outcome after spinal cord infarct varies according to the level and severity of initial neurologic deficits. Many patients improve with rehabilitation and time, but most have some persistent dysfunction. (See <a class="local">'Prognosis'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kramer CL. Vascular Disorders of the Spinal Cord. Continuum (Minneap Minn) 2018; 24:407.</a></li><li><a class="nounderline abstract_t">Zalewski NL, Rabinstein AA, Krecke KN, et al. Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria. JAMA Neurol 2019; 76:56.</a></li><li><a class="nounderline abstract_t">Thomas G, Alakbarzade V, Sammaraiee Y, et al. Spontaneous spinal cord infarction: a practical approach. Pract Neurol 2022; 22:497.</a></li><li><a class="nounderline abstract_t">Nasr DM, Rabinstein A. Spinal Cord Infarcts: Risk Factors, Management, and Prognosis. Curr Treat Options Neurol 2017; 19:28.</a></li><li><a class="nounderline abstract_t">Squair JW, Bélanger LM, Tsang A, et al. Empirical targets for acute hemodynamic management of individuals with spinal cord injury. Neurology 2019; 93:e1205.</a></li><li><a class="nounderline abstract_t">Epstein NE. Cerebrospinal fluid drains reduce risk of spinal cord injury for thoracic/thoracoabdominal aneurysm surgery: A review. Surg Neurol Int 2018; 9:48.</a></li><li><a class="nounderline abstract_t">McGarvey ML, Cheung AT, Szeto W, Messe SR. Management of neurologic complications of thoracic aortic surgery. J Clin Neurophysiol 2007; 24:336.</a></li><li><a class="nounderline abstract_t">Iampreechakul P, Liengudom A, Wangtanaphat K, et al. Intramedullary Hemorrhage Caused by Lumbosacral Epidural Arteriovenous Fistula with Dual Retrograde Perimedullary Venous Draining Routes: A Case Report and Review of the Literature. World Neurosurg 2020; 143:295.</a></li><li><a class="nounderline abstract_t">Miglis MG, Levine DN. Intracranial venous thrombosis after placement of a lumbar drain. Neurocrit Care 2010; 12:83.</a></li><li><a class="nounderline abstract_t">Restrepo L, Guttin JF. Acute spinal cord ischemia during aortography treated with intravenous thrombolytic therapy. Tex Heart Inst J 2006; 33:74.</a></li><li><a class="nounderline abstract_t">Baba H, Tomita K, Kawagishi T, Imura S. Anterior spinal artery syndrome. Int Orthop 1993; 17:353.</a></li><li><a class="nounderline abstract_t">Sakurai T, Wakida K, Nishida H. Cervical Posterior Spinal Artery Syndrome: A Case Report and Literature Review. J Stroke Cerebrovasc Dis 2016; 25:1552.</a></li><li><a class="nounderline abstract_t">Jankovic J, Rey Bataillard V, Mercier N, et al. Acute ischemic myelopathy treated with intravenous thrombolysis: Four new cases and literature review. Int J Stroke 2019; 14:893.</a></li><li><a class="nounderline abstract_t">Cook AM, Morgan Jones G, Hawryluk GWJ, et al. Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients. Neurocrit Care 2020; 32:647.</a></li><li><a class="nounderline abstract_t">Torbey MT, Bösel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine. Neurocrit Care 2015; 22:146.</a></li><li><a class="nounderline abstract_t">Nasr DM, Brinjikji W, Rabinstein AA, Lanzino G. Clinical outcomes following corticosteroid administration in patients with delayed diagnosis of spinal arteriovenous fistulas. J Neurointerv Surg 2017; 9:607.</a></li><li><a class="nounderline abstract_t">Cheung AT, Weiss SJ, McGarvey ML, et al. Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction. Ann Thorac Surg 2002; 74:413.</a></li><li><a class="nounderline abstract_t">Cheung AT, Pochettino A, McGarvey ML, et al. Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms. Ann Thorac Surg 2005; 80:1280.</a></li><li><a class="nounderline abstract_t">McGarvey ML, Mullen MT, Woo EY, et al. The treatment of spinal cord ischemia following thoracic endovascular aortic repair. Neurocrit Care 2007; 6:35.</a></li><li><a class="nounderline abstract_t">Zalewski NL, Rabinstein AA, Krecke KN, et al. Spinal cord infarction: Clinical and imaging insights from the periprocedural setting. J Neurol Sci 2018; 388:162.</a></li><li class="breakAll">Hurst RW. Spinal vascular disorders. In: Magnetic Resonance Imaging of the Brain and Spine, 2nd ed, Atlas SW (Ed), Lippincott, Philadelphia 2006. p.1387.</li><li><a class="nounderline abstract_t">Van Dijk JM, TerBrugge KG, Willinsky RA, et al. Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients. Stroke 2002; 33:1578.</a></li><li><a class="nounderline abstract_t">Cheshire WP, Santos CC, Massey EW, Howard JF Jr. Spinal cord infarction: etiology and outcome. Neurology 1996; 47:321.</a></li><li><a class="nounderline abstract_t">Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol 2006; 63:1113.</a></li><li><a class="nounderline abstract_t">Masson C, Pruvo JP, Meder JF, et al. Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome. J Neurol Neurosurg Psychiatry 2004; 75:1431.</a></li><li><a class="nounderline abstract_t">Robertson CE, Brown RD Jr, Wijdicks EF, Rabinstein AA. Recovery after spinal cord infarcts: long-term outcome in 115 patients. Neurology 2012; 78:114.</a></li><li><a class="nounderline abstract_t">Latoś T, Markiewicz R, Gaszczyk G. [Spirographic studies and measurement of airflow resistance in evaluation of bronchial hyperreactivity in children with asthma]. Pneumonol Pol 1990; 58:107.</a></li><li><a class="nounderline abstract_t">Nedeltchev K, Loher TJ, Stepper F, et al. Long-term outcome of acute spinal cord ischemia syndrome. Stroke 2004; 35:560.</a></li><li><a class="nounderline abstract_t">Salvador de la Barrera S, Barca-Buyo A, Montoto-Marqués A, et al. Spinal cord infarction: prognosis and recovery in a series of 36 patients. Spinal Cord 2001; 39:520.</a></li><li><a class="nounderline abstract_t">Iseli E, Cavigelli A, Dietz V, Curt A. Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation. J Neurol Neurosurg Psychiatry 1999; 67:567.</a></li><li><a class="nounderline abstract_t">Ros Castelló V, Sánchez Sánchez A, Natera Villalba E, et al. Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients. Neurologia (Engl Ed) 2023; 38:391.</a></li><li><a class="nounderline abstract_t">Stenimahitis V, Fletcher-Sandersjöö A, El-Hajj VG, et al. Long-term Outcomes After Periprocedural and Spontaneous Spinal Cord Infarctions: A Population-Based Cohort Study. Neurology 2023; 101:e114.</a></li><li class="breakAll">Geldmacher DS, Bowen BC. Vascular disease of the nervous system. In: Neurology in Clinical Practice, 4th ed, Bradley WG, Daroff RB, Fenichel GM, Jankovic J (Eds), Butterworth Heinemann, Philadelphia 2004. p.1313.</li><li><a class="nounderline abstract_t">Cheng MY, Lyu RK, Chang YJ, et al. Spinal cord infarction in Chinese patients. Clinical features, risk factors, imaging and prognosis. Cerebrovasc Dis 2008; 26:502.</a></li></ol></div><div id="topicVersionRevision">Topic 1115 Version 12.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29613893" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Vascular Disorders of the Spinal Cord.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30264146" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Characteristics of Spontaneous Spinal Cord Infarction and Proposed Diagnostic Criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35835550" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Spontaneous spinal cord infarction: a practical approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28688063" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Spinal Cord Infarcts: Risk Factors, Management, and Prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31409736" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Empirical targets for acute hemodynamic management of individuals with spinal cord injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29541489" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Cerebrospinal fluid drains reduce risk of spinal cord injury for thoracic/thoracoabdominal aneurysm surgery: A review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17938602" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Management of neurologic complications of thoracic aortic surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32791223" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Intramedullary Hemorrhage Caused by Lumbosacral Epidural Arteriovenous Fistula with Dual Retrograde Perimedullary Venous Draining Routes: A Case Report and Review of the Literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19834826" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Intracranial venous thrombosis after placement of a lumbar drain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16572877" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Acute spinal cord ischemia during aortography treated with intravenous thrombolytic therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8163309" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Anterior spinal artery syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27012218" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Cervical Posterior Spinal Artery Syndrome: A Case Report and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31092154" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Acute ischemic myelopathy treated with intravenous thrombolysis: Four new cases and literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32227294" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Guidelines for the Acute Treatment of Cerebral Edema in Neurocritical Care Patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25605626" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Evidence-based guidelines for the management of large hemispheric infarction : a statement for health care professionals from the Neurocritical Care Society and the German Society for Neuro-intensive Care and Emergency Medicine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27260973" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Clinical outcomes following corticosteroid administration in patients with delayed diagnosis of spinal arteriovenous fistulas.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12173822" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Interventions for reversing delayed-onset postoperative paraplegia after thoracic aortic reconstruction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16181855" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Strategies to manage paraplegia risk after endovascular stent repair of descending thoracic aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17356189" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : The treatment of spinal cord ischemia following thoracic endovascular aortic repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29627015" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Spinal cord infarction: Clinical and imaging insights from the periprocedural setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29627015" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Spinal cord infarction: Clinical and imaging insights from the periprocedural setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12052994" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Multidisciplinary management of spinal dural arteriovenous fistulas: clinical presentation and long-term follow-up in 49 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8757000" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Spinal cord infarction: etiology and outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16908737" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15377691" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Spinal cord infarction: clinical and magnetic resonance imaging findings and short term outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22205760" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Recovery after spinal cord infarcts: long-term outcome in 115 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2352879" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : [Spirographic studies and measurement of airflow resistance in evaluation of bronchial hyperreactivity in children with asthma].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14726546" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Long-term outcome of acute spinal cord ischemia syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11641795" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Spinal cord infarction: prognosis and recovery in a series of 36 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10519858" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Prognosis and recovery in ischaemic and traumatic spinal cord injury: clinical and electrophysiological evaluation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34130946" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Spinal cord infarction: aetiology, imaging findings, and prognostic factors in a series of 41 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37202170" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Long-term Outcomes After Periprocedural and Spontaneous Spinal Cord Infarctions: A Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37202170" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Long-term Outcomes After Periprocedural and Spontaneous Spinal Cord Infarctions: A Population-Based Cohort Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18810237" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Spinal cord infarction in Chinese patients. Clinical features, risk factors, imaging and prognosis.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
